IP Library Granted Patent US 12,048,844
Granted Patent B2
US 12,048,844 · App. 17/173,121 · Granted Jul 30, 2024

Modular stimulator for treatment of back pain, implantable RF ablation system and methods of use

Inventors: Peter Andrew Crosby (Blaine, MN); Dan Sachs (Minneapolis, MN); Prashant Brijmohansingh Rawat (Blaine, MN); Jason Alan Shiroff (Edina, MN); Johannes Petrus Heemels (Keerbergen, BE)
Assignee: Mainstay Medical Limited
A61N1/0551A61B18/1492A61N1/06A61N1/36071A61N1/37211A61B2017/00221A61B2018/00339A61B2018/00577A61B2018/124A61B2018/1467A61B2034/2048A61N1/36042
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,048,844
App. No.
17/173,121
Granted
Jul 30, 2024
Kind
B2
Abstract

Apparatus and methods for treating back pain are provided, in which an implantable stimulator is configured to communicate with an external control system, the implantable stimulator providing a neuromuscular electrical stimulation therapy designed to cause muscle contraction to rehabilitate the muscle, restore neural drive and restore spinal stability; the implantable stimulator further including one or more of a number of additional therapeutic modalities, including a module that provides analgesic stimulation; a module that monitors muscle performance and adjusts the muscle stimulation regime; and/or a module that provides longer term pain relief by selectively and repeatedly ablating nerve fibers. In an alternative embodiment, a standalone implantable RF ablation system is described.

Claims (28)

1. A therapeutic electrical stimulation system comprising:

a stimulator housing;

an electrode lead coupled to the stimulator housing and comprising one or more electrodes, the electrode lead configured to be implanted in or adjacent to a tissue associated with a spine of a patient;

a circuitry module disposed within the stimulator housing and operatively coupled to the electrode lead, the circuitry module configured to deliver neuromuscular stimulation and analgesic stimulation to the one or more electrodes to the tissue associated with the spine of the patient; and

a controller disposed within the stimulator housing and operatively coupled to the circuitry module, the controller configured to cause simultaneous delivery of the neuromuscular stimulation and the analgesic stimulation to the one or more electrodes via the circuitry module to effect pain relief or pain reduction in the patient.

2. The system of claim 1 , wherein the electrode lead is configured to be implanted in or adjacent to a medial branch of a dorsal ramus.

3. The system of claim 2 , wherein the medial branch of the dorsal ramus is located in the lumbar spine of the patient.

4. The system of claim 1 , wherein the circuitry module is configured to deliver RF energy to the one or more electrodes for repeated ablation of the tissue associated with the spine of the patient after a predetermined period of time.

5. The system of claim 4 , further comprising one or more sensors configured to monitor tissue temperature adjacent to the one or more electrodes.

6. The system of claim 1 , further comprising a telemetry system disposed within the stimulator housing and operatively coupled to the controller.

7. The system of claim 6 , further comprising an external control system configured to wirelessly communicate with the telemetry system.

8. The system of claim 7 , wherein the external control system is configured to transmit stimulation operating parameters to the controller via the telemetry system.

9. The system of claim 7 , wherein the external control system is configured to transmit energy to a power source disposed within the stimulator housing via the telemetry system.

10. The system of claim 7 , further comprising a battery within the stimulator housing,

wherein the controller is configured to transmit data indicative of at least one of impedance between electrodes, temperature of the battery, or battery status of the battery to the external control system via the telemetry system.

11. The system of claim 1 , further comprising a power source disposed within the stimulator housing, the power source configured to power the circuitry module.

12. The system of claim 1 , further comprising an electrode switching array disposed within the stimulator housing, the controller operatively coupled to the electrode switching array to select a subset of the one or more electrodes to deliver at least one of the neuromuscular stimulation or the analgesic stimulation.

13. The system of claim 12 , wherein the controller is configured to select the subset of the one or more electrodes to compensate for electrode migration post-implantation.

14. The system of claim 1 , further comprising one or more sensors operatively coupled to the electrode lead and configured to monitor tissue impedance.

15. The system of claim 1 , wherein the circuitry module is configured to deliver the neuromuscular stimulation to a subset of the one or more electrodes to cause contraction of a spinal muscle associated with the tissue associated with the spine of the patient.

16. The system of claim 1 , wherein the circuitry module comprises a first circuitry module configured to cause delivery of the neuromuscular stimulation to efferent nerve fibers associated with the tissue associated with the spine of the patient and a second circuitry module configured to cause delivery of the analgesic stimulation to afferent nerve fibers associated with the tissue associated with the spine of the patient.

17. A method for relieving back pain, the method comprising:

implanting an electrode lead comprising one or more electrodes configured to be implanted in or adjacent to a tissue associated with a spine of a patient;

coupling said electrode lead to a circuitry module disposed within a stimulator housing, the stimulator housing comprising a controller configured to cause delivery of neuromuscular stimulation and analgesic stimulation to the one or more electrodes of the electrode lead via the circuitry module to effect pain relief or pain reduction in the patient; and

simultaneously delivering the neuromuscular stimulation and the analgesic stimulation to the one or more electrodes of the electrode lead via the controller to effect the pain relief or the pain reduction in the patient.

18. The method of claim 17 , wherein implanting the electrode lead comprises implanting the electrode lead in or adjacent to a medial branch of a dorsal ramus.

19. The method of claim 17 , further comprising selecting a subset of the one or more electrodes to deliver RF energy, and wherein delivering RF energy to the one or more electrodes comprises delivering RF energy to the selected subset of the one or more electrodes to compensate for electrode migration post-implantation.

20. The method of claim 17 , further comprising repeatedly delivering RF energy to the one or more electrodes to repeatedly ablate the tissue associated with the spine of the patient after a predetermined period of time.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 3, 2025
From: MADRYN FUND ADMINISTRATION, LLC
To: MAINSTAY MEDICAL LIMITED
Reel/Frame 070388/0062 →
SECURITY INTEREST Recorded Jan 24, 2024
From: MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 066367/0608 →
SECURITY INTEREST Recorded Sep 9, 2022
From: MAINSTAY MEDICAL LIMITED
To: MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP
Reel/Frame 061404/0708 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2021
From: CROSBY, PETER ANDREW; SACHS, DAN; RAWAT, PRASHANT BRIJMOHANSINGH; SHIROFF, JASON ALAN; HEEMELS, JOHANNES PETRUS
To: MAINSTAY MEDICAL, INC.
Reel/Frame 055220/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2021
From: MAINSTAY MEDICAL, INC.
To: MAINSTAY MEDICAL LIMITED
Reel/Frame 055220/0838 →
Continuity (8)
Continuation 16817574 · Mar 12, 2020
Continuation 15853543 · Dec 22, 2017
Continuation 14849478 · Sep 9, 2015
Continuation In Part 13045435 · Mar 10, 2011
Continuation 13045421 · Mar 10, 2011
Provisional Application 61339957 · Mar 11, 2010
Provisional Application 61339943 · Mar 11, 2010
Related Publication 20210162207A1 · Jun 3, 2021
Cited By (5)
US 12,285,612 US 12,458,802 US 12,582,816 US 12,594,096 US 12,702,824